Statements (44)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Trixeo_Aerosphere
|
| gptkbp:activities |
gptkb:drug
|
| gptkbp:appointed_by |
injection
oral tablet |
| gptkbp:approves |
gptkb:1961
gptkb:FDA |
| gptkbp:brand |
gptkb:Cuvposa
gptkb:Glycopyrrolate_Injection gptkb:Robinul |
| gptkbp:clinical_trial |
studied for COPD
studied for asthma studied for drooling in children studied for excessive sweating studied for postoperative nausea |
| gptkbp:contraindication |
gptkb:sneaker
gptkb:Insurance_Company urinary obstruction severe ulcerative colitis |
| gptkbp:formulation |
gptkb:skincare_product
oral solution sublingual tablet |
| https://www.w3.org/2000/01/rdf-schema#label |
glycopyrrolate
|
| gptkbp:ingredients |
C19 H28 Br N
|
| gptkbp:interacts_with |
antihistamines
muscle relaxants tricyclic antidepressants other anticholinergics |
| gptkbp:is_atype_of |
A03 B B01
|
| gptkbp:is_available_on |
generic drug
|
| gptkbp:is_used_for |
chronic obstructive pulmonary disease
treating peptic ulcers preoperative medication reducing drooling |
| gptkbp:pharmacokinetics |
half-life 1.5 to 2 hours
oral bioavailability 5% to 10% |
| gptkbp:side_effect |
dizziness
constipation dry mouth blurred vision urinary retention |
| gptkbp:storage |
store at room temperature
|
| gptkbp:type_of |
557-73-1
|